 |
|
Diabetes Drugs and Cardiovascular Safety
Ji Cheol Bae (Bae JC)
Endocrinol Metab. 2016;31(2):239-244. Published online 2016 Jun 10 DOI: https://doi.org/10.3803/EnM.2016.31.2.239
|
|
Citations to this article as recorded by
 Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
Kyoung Jin Kim, Jimi Choi, Juneyoung Lee, Jae Hyun Bae, Jee Hyun An, Hee Young Kim, Hye Jin Yoo, Ji A. Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
Cardiovascular Diabetology.2019;[Epub] CrossRef Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk
Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee
Diabetes, Obesity and Metabolism.2019; 21(4): 801. CrossRef Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
Cheng-Wei Chan, Chu-Leng Yu, Jiunn-Cherng Lin, Yu-Cheng Hsieh, Che-Chen Lin, Chen-Ying Hung, Cheng-Hung Li, Ying-Chieh Liao, Chu-Pin Lo, Jin-Long Huang, Ching-Heng Lin, Tsu-Juey Wu
Cardiovascular Diabetology.2018;[Epub] CrossRef Normoglucemiantes orales y riesgo cardiovascular
Guillermo Guzmán, Juan Esteban Gómez, Leidy Johanna Plaza, María Claudia Sánchez
Revista Colombiana de Cardiología.2018; 25(5): 333. CrossRef Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study
N.H. Kim, J. Choi, N.H. Kim, K.M. Choi, S.H. Baik, J. Lee, S.G. Kim
Diabetes & Metabolism.2018; 44(4): 361. CrossRef Obesity and Type 2 Diabetes in Our Youth: A Recipe for Cardiovascular Disease
Angela Kaye Wooton, Lynne M. Melchior
The Journal for Nurse Practitioners.2017; 13(3): 222. CrossRef Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes
Ilaria Campesi, Flavia Franconi, Giuseppe Seghieri, Marco Meloni
Pharmacological Research.2017; 119: 195. CrossRef The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis
Mona P. Nasrallah, Charbel Abi Khalil, Marwan M. Refaat
BioMed Research International.2017; 2017: 1. CrossRef Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
|